Human Plasmin Enzymatic Activity Is Inhibited by Chemically Modified Dextrans
Authors:
- Dulce Papy-GarciaDPDulce Papy-Garcia
- Quentin EscartinQEQuentin Escartin
- Marie-Astride SagotMSMarie-Astride Sagot
- Yihai CaoYCYihai Cao
- Denis BarritaultDBDenis Barritault
- Josiane CourtoisJCJosiane Courtois
- William HornebeckWHWilliam Hornebeck
- Jean-Pierre CaruelleJCJean-Pierre Caruelle
Open Access
- 1 September 2000
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (38) , 29383-29390
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- A substituted dextran enhances muscle fiber survival and regeneration in ischemic and denervated rat EDL muscleThe FASEB Journal, 1999
- ECM and Cell Surface Proteolysis: Regulating Cellular EcologyCell, 1997
- Kringle 5 of Plasminogen is a Novel Inhibitor of Endothelial Cell GrowthJournal of Biological Chemistry, 1997
- Heparin-like polymers derived from dextran enhance colonic anastomosis resistance to leakageJournal of Biomedical Materials Research, 1996
- FGF protection and inhibition of human neutrophil elastase by carboxymethyl benzylamide sulfonate dextran derivativesInternational Journal of Biological Macromolecules, 1996
- Heparan-like molecules induce the repair of skull defectsBone, 1995
- New Approaches to Tissue Regeneration and RepairPathology - Research and Practice, 1994
- CMDBS, Functional Analogue of Heparin Sulfate as a New Class of Corneal Ulcer Healing AgentsOphthalmic Research, 1994
- Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGFJournal of Cellular Physiology, 1992
- Proteinases and extracellular remodelingCurrent Opinion in Cell Biology, 1989